PCS-2023 > 3 > 3E > 3E0 > 3E0R |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E0R | Introduction, Spinal Canal | |
3E0R0 | Open | |
3E0R0A | Stem Cells, Embryonic | |
3E0R0AZ | Introduction of Embryonic Stem Cells into Spinal Canal, Open Approach | |
3E0R0E | Stem Cells, Somatic | |
3E0R0E0 | Introduction of Autologous Somatic Stem Cells into Spinal Canal, Open Approach | |
3E0R0E1 | Introduction of Nonautologous Somatic Stem Cells into Spinal Canal, Open Approach | |
3E0R3 | Percutaneous | |
3E0R30 | Antineoplastic | |
3E0R302 | Introduction of High-dose Interleukin-2 into Spinal Canal, Percutaneous Approach | |
3E0R303 | Introduction of Low-dose Interleukin-2 into Spinal Canal, Percutaneous Approach | |
3E0R304 | Introduction of Liquid Brachytherapy Radioisotope into Spinal Canal, Percutaneous Approach | |
3E0R305 | Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach | |
3E0R30M | Introduction of Antineoplastic, Monoclonal Antibody, into Spinal Canal, Percutaneous Approach | |
3E0R32 | Anti-infective | |
3E0R328 | Introduction of Oxazolidinones into Spinal Canal, Percutaneous Approach | |
3E0R329 | Introduction of Other Anti-infective into Spinal Canal, Percutaneous Approach | |
3E0R33 | Anti-inflammatory | |
3E0R33Z | Introduction of Anti-inflammatory into Spinal Canal, Percutaneous Approach | |
3E0R36 | Nutritional Substance | |
3E0R36Z | Introduction of Nutritional Substance into Spinal Canal, Percutaneous Approach | |
3E0R37 | Electrolytic and Water Balance Substance | |
3E0R37Z | Introduction of Electrolytic and Water Balance Substance into Spinal Canal, Percutaneous Approach | |
3E0R3A | Stem Cells, Embryonic | |
3E0R3AZ | Introduction of Embryonic Stem Cells into Spinal Canal, Percutaneous Approach | |
3E0R3B | Anesthetic Agent | |
3E0R3BZ | Introduction of Anesthetic Agent into Spinal Canal, Percutaneous Approach | |
3E0R3H | Radioactive Substance | |
3E0R3HZ | Introduction of Radioactive Substance into Spinal Canal, Percutaneous Approach | |
3E0R3K | Other Diagnostic Substance | |
3E0R3KZ | Introduction of Other Diagnostic Substance into Spinal Canal, Percutaneous Approach | |
3E0R3N | Analgesics, Hypnotics, Sedatives | |
3E0R3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Spinal Canal, Percutaneous Approach | |
3E0R3T | Destructive Agent | |
3E0R3TZ | Introduction of Destructive Agent into Spinal Canal, Percutaneous Approach | |
3E0R3E | Stem Cells, Somatic | |
3E0R3E0 | Introduction of Autologous Somatic Stem Cells into Spinal Canal, Percutaneous Approach | |
3E0R3E1 | Introduction of Nonautologous Somatic Stem Cells into Spinal Canal, Percutaneous Approach | |
3E0R3G | Other Therapeutic Substance | |
3E0R3GC | Introduction of Other Therapeutic Substance into Spinal Canal, Percutaneous Approach | |
3E0R3S | Gas | |
3E0R3SF | Introduction of Other Gas into Spinal Canal, Percutaneous Approach | |
3E0R7 | Via Natural or Artificial Opening | |
3E0R7S | Gas | |
3E0R7SF | Introduction of Other Gas into Spinal Canal, Via Natural or Artificial Opening |
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |